EUVIMEDEUVIMED entdecken
Crossref

N-[2-(4-Methylphenyl)Ethyl]-N′-[2-(5-Bromopyridyl)]-Thiourea as a Potent Inhibitor of NNRTI-Resistant and Multidrug-Resistant Human Immunodeficiency Virus Type 1

F M Uckun, C Mao, S Pendergrass, D Maher, D Zhu, L Tuel-Ahlgren, T K Venkatachalam

Antiviral Chemistry and Chemotherapy · 2000

DOI: 10.1177/095632020001100205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antiviral Chemistry and Chemotherapy, 2000. Verfasst von F M Uckun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Parker Hughes Institute, St Paul, Minn., USA. Fatih_Uckun@mercury.ih.org. Hauptthemen laut MEDLINE: Drug Resistance, Multiple. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The composite non-nucleoside reverse transcriptase inhibitor (NNRTI) binding pocket model was used to study a number of thiourea analogues with different substitutions at the 4-phenyl position including N-[2-(4-methylphenyl)ethyl]-N′-[2-(5-bromopyridyl)]-thiourea (compound HI-244), which inhibited recombinant RT better than trovirdine or compound HI-275 with an unsubstituted phenyl ring. HI-244 effectively inhibited the replication of HIV-1 strain HTLV IIIB in human peripheral blood mononuclear cells with an IC 50 value of 0.007 μM, which is equal to the IC 50 value of trovirdine. Notably, HI-244 was 20 times more effective than trovirdine against the multidrug-resistant HIV-1 strain RT-MDR with a V106A mutation (as well as additional mutations involving the RT residues 74 V, 41L and 215Y) and seven times more potent than trovirdine against the NNRTI- resistant HIV-1 strain A17 with a Y181C mutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, MultipleAnti-HIV AgentsBinding SitesHIV-1HumansInhibitory Concentration 50Leukocytes, MononuclearModels, MolecularProtein ConformationPyridinesRNA-Directed DNA PolymeraseRecombinant ProteinsReverse Transcriptase InhibitorsStructure-Activity RelationshipThioureaVirus Replication

Substanzen

Anti-HIV AgentsHI 244PyridinesRecombinant ProteinsReverse Transcriptase InhibitorsRNA-Directed DNA PolymeraseThiourea

Autor:innen und Institutionen

  • Department of Virology, Parker Hughes Institute, St Paul, Minn., USA. Fatih_Uckun@mercury.ih.org

Zitieren

APA

Uckun, F. M., Mao, C., Pendergrass, S., Maher, D., Zhu, D., Tuel-Ahlgren, L., & Venkatachalam, T. K. (2000). N-[2-(4-Methylphenyl)Ethyl]-N′-[2-(5-Bromopyridyl)]-Thiourea as a Potent Inhibitor of NNRTI-Resistant and Multidrug-Resistant Human Immunodeficiency Virus Type 1. Antiviral Chemistry and Chemotherapy. https://doi.org/10.1177/095632020001100205

Vancouver

Uckun FM, Mao C, Pendergrass S, Maher D, Zhu D, Tuel-Ahlgren L, et al. N-[2-(4-Methylphenyl)Ethyl]-N′-[2-(5-Bromopyridyl)]-Thiourea as a Potent Inhibitor of NNRTI-Resistant and Multidrug-Resistant Human Immunodeficiency Virus Type 1. Antiviral Chemistry and Chemotherapy. 2000. doi:10.1177/095632020001100205

BibTeX
@article{Uckun2000,
  author = {Uckun, F M and Mao, C and Pendergrass, S and Maher, D and Zhu, D and Tuel-Ahlgren, L and Venkatachalam, T K},
  title = {N-[2-(4-Methylphenyl)Ethyl]-N′-[2-(5-Bromopyridyl)]-Thiourea as a Potent Inhibitor of NNRTI-Resistant and Multidrug-Resistant Human Immunodeficiency Virus Type 1},
  journal = {Antiviral Chemistry and Chemotherapy},
  year = {2000},
  doi = {10.1177/095632020001100205}
}
Kostenlos starten →